Minakem Generic APIs Minakem Generic APIs

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Granules India Limited aggregated by PharmaCompass.com.

    Client Virtual Booth

    GRANULES INDIA LIMITED

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    Key Products KEY PRODUCTS

    • Avatrombopag Maleate

    • Bupropion Hydrobromide

    • Bupropion Hydrochloride

    • Cabozantinib

    • Elacestrant

    • Eltrombopag

    • Esomeprazole Magnesium

    • Esomeprazole Sodium

    • Gabapentin

    • Gabapentin Enacarbil

    • Guaifenesin

    • Metformin

    • Methocarbamol

    • Metoprolol Fumarate

    • Metoprolol Succinate

    • Metoprolol Tartrate

    • Paracetamol

    • Ruxolitinib Phosphate

    • Sitagliptin Hydrochloride

    • Sitagliptin Malate

    • Sitagliptin Phosphate

    • Trazodone Hydrochloride

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Granules India
    Granules India Limited
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad- 500 081 (TG)
    Telephone
    Telephone
    +91 4069043500
    Client Email
    Email
    mail@granulesindia.com
    Client Website
    Website
    https://granulesindia.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/granules-india-limited/
    Twitter
    Twitter
    https://twitter.com/GranulesIndia
    Contact Info
    Others

    Full View ScreenFull Screen View
    Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
    Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion

    https://www.reuters.com/business/healthcare-pharmaceuticals/granules-india-posts-q4-revenue-fall-weak-paracetamol-sales-price-erosion-2024-05-15/

    REUTERS
    14 May 2024
    Share Share
    Granules India Annual Financial Results – FY24
    Granules India Annual Financial Results – FY24

    https://granulesindia.com/wp-content/uploads/2024/05/Press-Release-Q4-FY24-.pdf

    PRESS RELEASE
    30 Apr 2024
    Share Share
    Granules India Announced ANDA Approval for Colchicine Capsules
    Granules India Announced ANDA Approval for Colchicine Capsules

    https://granulesindia.com/wp-content/uploads/2024/04/Granules-India-Limited-Announced-ANDA-Approval-for-Colchicine-Capsules.pdf

    PRESS RELEASE
    30 Apr 2024
    Share Share
    Granules India’s Vizag facility completes US FDA inspection with zero 483
    Granules India’s Vizag facility completes US FDA inspection with zero 483

    https://www.expresspharma.in/granules-indias-vizag-facility-completes-us-fda-inspection-with-zero-483-observations/

    EXPRESSPHARMA
    15 Apr 2024
    Share Share
    Granules India Unit V facility in Andhra Pradesh's Anakapally gets Zero 483
    Granules India Unit V facility in Andhra Pradesh's Anakapally gets Zero 483

    https://www.cnbctv18.com/business/companies/stocks-in-news-graunles-india-share-price-performance-usfda-inspection-andhra-facility-form-483-19396180.htm

    CNBC
    12 Apr 2024
    Share Share
    Granules, NIPER-Mohali ink pact to establish centre of excellence
    Granules, NIPER-Mohali ink pact to establish centre of excellence

    https://www.thehindu.com/news/cities/Hyderabad/granules-niper-mohali-ink-pact-to-establish-centre-of-excellence-in-innovative-sustainable-pharma-development/article67427535.ece

    THEHINDU
    01 Feb 2024
    Share Share
    Paracetamol maker Granules India posts marginal rise in Q3 profit
    Paracetamol maker Granules India posts marginal rise in Q3 profit

    https://www.reuters.com/business/healthcare-pharmaceuticals/paracetamol-maker-granules-india-posts-marginal-rise-q3-profit-2024-01-23/

    REUTERS
    23 Jan 2024
    Share Share
    Granules India Generic gets USFDA nod for Pantoprazole Sodium
    Granules India Generic gets USFDA nod for Pantoprazole Sodium

    https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/granules-india-gets-usfda-nod-for-generic-pantoprazole-sodium-tablets/105964031

    ECONOMICTIMES
    13 Dec 2023
    Share Share
    Granules' Generic Sildenafil Citrate Receives Approval in the U.S.
    Granules' Generic Sildenafil Citrate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214556

    FDA
    01 Dec 2023
    Share Share
    Granules gets FDA nod for generic drug used for treatment of heartburn
    Granules gets FDA nod for generic drug used for treatment of heartburn

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-india-gets-usfda-nod-for-generic-drug-used-for-short-term-treatment-of-heartburn/articleshow/104550296.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    19 Oct 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Granules India

    CPhI Worldwide, Milan

    Booth #22A34

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search